Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma

Today, individual prognosis in patients with adenocarcinoma of the esophagus (EAC) is based on post-surgical TNM staging and valid biomarkers are still not implemented. Integrin beta1 (ITGB1) is widely expressed in epithelial cells and promotes cell adhesion and growth. Its impact on tumor progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Damanakis, Alexander I., Wahler, Isabell, Fuchs, Hans, Löser, Heike, Schröder, Wolfgang, Zander, Thomas, Chon, Seung-Hun, Bruns, Christiane, Quaas, Alexander, Gebauer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715537/
https://www.ncbi.nlm.nih.gov/pubmed/36456612
http://dx.doi.org/10.1038/s41598-022-25071-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715537/
https://www.ncbi.nlm.nih.gov/pubmed/36456612
http://dx.doi.org/10.1038/s41598-022-25071-y

Ejemplares similares